España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Nurix Therapeutics
NRIX
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$22.37
-0.27
-1.19%
At close: -
$22.37
0
0.00%
After Hours: 4:00 PM EDT
Get Report
Comment
Nurix Therapeutics (NRIX) Forecast
News
Earnings
Nurix Therapeutics (NRIX) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Nurix Therapeutics (NASDAQ:NRIX) Stock
Nurix Therapeutics Stock (NASDAQ: NRIX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, November 20, 2024
Nurix Therapeutics Receives PRIME Designation...
Benzinga Newsdesk
Monday, November 18, 2024
Reported Sunday, Nurix Therapeutics Showcased...
Benzinga Newsdesk
Wednesday, November 06, 2024
The Analyst Verdict: Nurix Therapeutics In The Eyes Of 10 Experts
Benzinga Insights
Needham Reiterates Buy on Nurix Therapeutics,...
Benzinga Newsdesk
Tuesday, November 05, 2024
Nurix Therapeutics To Present Data At 66th AS...
Benzinga Newsdesk
Thursday, October 31, 2024
Cathie Wood's Ark Innovation, Genomic ETFs Celebrate 10 Years: How Annual Returns Stack Up Against S&P 500
Chris Katje
Thursday, October 24, 2024
UBS Initiates Coverage On Nurix Therapeutics ...
Benzinga Newsdesk
Monday, October 21, 2024
Needham Reiterates Buy on Nurix Therapeutics,...
Benzinga Newsdesk
HC Wainwright & Co. Maintains Buy on Nurix Th...
Benzinga Newsdesk
Reported Saturday, Nurix Therapeutics Present...
Benzinga Newsdesk
Monday, October 14, 2024
Wells Fargo To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Monday
Avi Kapoor
RBC Capital Maintains Outperform on Nurix The...
Benzinga Newsdesk
Stephens & Co. Reiterates Overweight on Nurix...
Benzinga Newsdesk
Needham Reiterates Buy on Nurix Therapeutics,...
Benzinga Newsdesk
Boeing, Nurix Therapeutics And 3 Stocks To Watch Heading Into Monday
Avi Kapoor
Friday, October 11, 2024
Nurix Therapeutics shares are trading higher ...
Benzinga Newsdesk
Nurix Therapeutics Q3 2024 GAAP EPS $(0.67) B...
Benzinga Newsdesk
Unveiling 6 Analyst Insights On Nurix Therapeutics
Benzinga Insights
Nurix Therapeutics shares are trading higher ...
Benzinga Newsdesk
This Amazon Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
Avi Kapoor
Jefferies Initiates Coverage On Nurix Therape...
Benzinga Newsdesk
Thursday, October 10, 2024
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
Wednesday, October 09, 2024
Nurix Therapeutics Will Present Preclinical D...
Benzinga Newsdesk
Wednesday, September 04, 2024
Analyst Ratings For Nurix Therapeutics
Benzinga Insights
Oppenheimer Maintains Outperform on Nurix The...
Benzinga Newsdesk
Wednesday, August 14, 2024
TJX To Rally Over 15%? Here Are 10 Top Analyst Forecasts For Wednesday
Avi Kapoor
Oppenheimer Maintains Outperform on Nurix The...
Benzinga Newsdesk
Wednesday, July 31, 2024
Nurix Therapeutics shares are trading higher ...
Benzinga Newsdesk
Forecasting The Future: 13 Analyst Projections For Nurix Therapeutics
Benzinga Insights
Truist Securities Initiates Coverage On Nurix...
Benzinga Newsdesk
Monday, July 15, 2024
Analyst Scoreboard: 12 Ratings For Nurix Therapeutics
Benzinga Insights
JP Morgan Maintains Overweight on Nurix Thera...
Benzinga Newsdesk
Barclays Maintains Overweight on Nurix Therap...
Benzinga Newsdesk
Friday, July 12, 2024
RBC Capital Maintains Outperform on Nurix The...
Benzinga Newsdesk
Needham Maintains Buy on Nurix Therapeutics, ...
Benzinga Newsdesk
Thursday, July 11, 2024
Nurix Says Enters H2 Of 2024 Well Positioned ...
Benzinga Newsdesk
Nurix Therapeutics Q2 2024 GAAP EPS $(0.71) M...
Benzinga Newsdesk
Thursday, June 27, 2024
Expert Outlook: Nurix Therapeutics Through The Eyes Of 14 Analysts
Benzinga Insights
RBC Capital Maintains Outperform on Nurix The...
Benzinga Newsdesk
Tuesday, June 25, 2024
Beyond Air, Inc. Reports Q4 Loss, Misses Revenue Estimates
Zacks
Tuesday, June 18, 2024
Nurix Therapeutics shares are trading higher ...
Benzinga Newsdesk
Nvidia To Rally Around 53%? Here Are 10 Top Analyst Forecasts For Tuesday
Avi Kapoor
HC Wainwright & Co. Maintains Buy on Nurix Th...
Benzinga Newsdesk
Monday, June 17, 2024
What's Going On With Small-Cap Cancer Focused Nurix Therapeutics On Monday?
Vandana Singh
JP Morgan Maintains Overweight on Nurix Thera...
Benzinga Newsdesk
Why Nurix Therapeutics Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Nurix Therapeutics shares are trading higher ...
Benzinga Newsdesk
Needham Reiterates Buy on Nurix Therapeutics,...
Benzinga Newsdesk
Reported Sunday, Nurix Therapeutics Confirms ...
Benzinga Newsdesk
Tuesday, June 11, 2024
Nurix Therapeutics Inc Files For Mixed Shelf;...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch